Patient Terms and Conditions: Update effective as of September 1, 2024. Patients must have minimum out-of-pocket costs of $.01 to redeem this offer. Annual benefit maximum applies, as may other restrictions. Patients will be responsible for any out-of-pocket costs above the maximum annual program benefit. Program benefit applies to medication cost only and does not cover any costs to administer the medication. Offer with program member number is valid through December 31 of the year of issue. On January 1 of the following year, the offer automatically resets and is subject to annual limits if the prescription benefit remains the same. Patients must have commercial prescription benefit coverage. Offer is not valid if a patient is uninsured, is paying cash for the treatment, or is covered by an Alternate Funding Program (AFP). Offer is not valid if a patient is enrolled in a federal or state prescription program (including Medicare Part B, Medicare Advantage, Medicaid, TRICARE, or any state medical or pharmaceutical assistance program). Patient enrollment in a copay adjustment program, such as a maximizer or accumulator program, may impact the value of this offer. If patients move or switch from commercial prescription benefit coverage to any government prescription benefit coverage, they will no longer be eligible. This offer is not insurance. Offer is valid only for an FDA-approved or compendia-recognized use. Patients are responsible for reporting receipt of program benefits to any commercial insurer that pays for or reimburses any part of the prescriptions filled with this program to the extent required by law or by the insurer. Patients agree not to seek reimbursement from their insurer or any other third party for all or any part of the benefit received through this offer. This offer may not be sold, purchased, traded, or transferred and is void if reproduced. Use of this offer does not obligate the patient to use or continue to use Niktimvo™ (axatilimab-csfr). No other purchase and no refills are necessary. This offer is limited to one (1) per person during this offering period. Patient is responsible for all taxes. There are no membership fees associated with this program. Offer is good only in the United States and Puerto Rico and is void where prohibited or otherwise restricted by law. Incyte Corporation reserves the right to rescind, revoke, or amend this program without notice. If questions arise, please call 1-855-452-5234.
INDICATIONS AND USAGE
Niktimvo™ (axatilimab-csfr) is a prescription medicine used to treat adults and children who weigh at least 88.2 pounds (40 kg) with chronic graft-versus-host disease (cGVHD) after receiving at least 2 prior treatments (systemic therapy) and they did not work.
It is not known if Niktimvo is safe and effective in adults and children weighing less than 88.2 pounds (40 kg).
IMPORTANT SAFETY INFORMATION
What are the possible side effects of Niktimvo™ (axatilimab-csfr)?
Niktimvo may cause serious side effects, including:
Infusion-related reactions: Infusion-related reactions are common with Niktimvo and can be serious. Your healthcare provider will monitor you for infusion-related reactions during your treatment. If you have a reaction, your healthcare provider may temporarily or completely stop your treatment with Niktimvo. Tell your healthcare provider right away if you have fever, chills, rash, flushing, shortness of breath, trouble breathing, nausea, vomiting, or symptoms of high blood pressure such as chest pain, headaches, or blurred vision during an infusion of Niktimvo.
The most common side effects of Niktimvo include:
- infections
- increased blood level of liver enzymes
- decreased blood level of phosphate
- low red blood cell count (anemia)
- muscle, bone, or joint pain
- increased blood level of pancreatic enzymes
- low energy
- increased blood level of calcium
- increased blood level of a muscle enzyme
- increased blood level of a bone enzyme
- nausea
- headache
- diarrhea
- cough
- fever
- shortness of breath
These are not all the possible side effects of Niktimvo. Call your doctor for medical advice about side effects.
Before receiving Niktimvo, tell your healthcare provider about all of your medical conditions, including if you:
- have or have had liver problems.
are pregnant or plan to become pregnant. Niktimvo may harm your unborn baby. Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with Niktimvo.
- You should use an effective method of birth control during your treatment and for 30 days after your last dose of Niktimvo. Talk to your healthcare provider about birth control methods that you can use during this time.
- Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Niktimvo.
- are breastfeeding or plan to breastfeed. It is not known if Niktimvo passes into your breast milk. Do not breastfeed during treatment and for 30 days after your last dose of Niktimvo.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
You may also report side effects to Incyte Medical Information at 1-855-463-3463.
INDICATIONS AND USAGE
Niktimvo™ (axatilimab-csfr) is a prescription medicine used to treat adults and children who weigh at least 88.2 pounds (40 kg) with chronic graft-versus-host disease (cGVHD) after receiving at least 2 prior treatments (systemic therapy) and they did not work.
It is not known if Niktimvo is safe and effective in adults and children weighing less than 88.2 pounds (40 kg).
IMPORTANT SAFETY INFORMATION
What are the possible side effects of Niktimvo™ (axatilimab-csfr)?
Niktimvo may cause serious side effects, including:
Infusion-related reactions: Infusion-related reactions are common with Niktimvo and can be serious. Your healthcare provider will monitor you for infusion-related reactions during your treatment. If you have a reaction, your healthcare provider may temporarily or completely stop your treatment with Niktimvo. Tell your healthcare provider right away if you have fever, chills, rash, flushing, shortness of breath, trouble breathing, nausea, vomiting, or symptoms of high blood pressure such as chest pain, headaches, or blurred vision during an infusion of Niktimvo.
The most common side effects of Niktimvo include:
- infections
- increased blood level of liver enzymes
- decreased blood level of phosphate
- low red blood cell count (anemia)
- muscle, bone, or joint pain
- increased blood level of pancreatic enzymes
- low energy
- increased blood level of calcium
- increased blood level of a muscle enzyme
- increased blood level of a bone enzyme
- nausea
- headache
- diarrhea
- cough
- fever
- shortness of breath
These are not all the possible side effects of Niktimvo. Call your doctor for medical advice about side effects.
Before receiving Niktimvo, tell your healthcare provider about all of your medical conditions, including if you:
- have or have had liver problems.
are pregnant or plan to become pregnant. Niktimvo may harm your unborn baby. Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with Niktimvo.
- You should use an effective method of birth control during your treatment and for 30 days after your last dose of Niktimvo. Talk to your healthcare provider about birth control methods that you can use during this time.
- Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Niktimvo.
- are breastfeeding or plan to breastfeed. It is not known if Niktimvo passes into your breast milk. Do not breastfeed during treatment and for 30 days after your last dose of Niktimvo.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
You may also report side effects to Incyte Medical Information at 1-855-463-3463.